Cardinal Health (CAH) Stock Forecast & Price Target

$117.92 -1.22 (-1.02%)

(As of 05:46 PM ET)

Cardinal Health - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 13 Analyst Ratings

Sell
0

Hold
5

Buy
8

Based on 13 Wall Street analysts who have issued ratings for Cardinal Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 13 analysts, 5 have given a hold rating, and 8 have given a buy rating for CAH.

Consensus Price Target

$127.50
8.12% Upside

According to the 13 analysts' twelve-month price targets for Cardinal Health, the average price target is $127.50. The highest price target for CAH is $139.00, while the lowest price target for CAH is $107.00. The average price target represents a forecasted upside of 8.12% from the current price of $117.92.

Get the Latest News and Ratings for CAH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cardinal Health and its competitors.

CAH Analyst Ratings Over Time

Type	Current Forecast 12/31/23 to 12/30/24	1 Month Ago 12/1/23 to 11/30/24	3 Months Ago 10/2/23 to 10/1/24	1 Year Ago 12/31/22 to 12/31/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	7 Buy rating(s)	7 Buy rating(s)	3 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$127.50	$123.00	$119.36	$96.77
Forecasted Upside	8.12% Upside	0.62% Upside	8.19% Upside	-4.00% Downside
Consensus Rating	Moderate Buy	Hold	Moderate Buy	Hold

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

CAH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CAH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cardinal Health Stock vs. The Competition

Type	Cardinal Health	Medical Companies	S&P 500
Consensus Rating Score	2.62	2.81	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	8.12% Upside	24,345.89% Upside	15.22% Upside
News Sentiment Rating	Neutral News See Recent CAH News	Positive News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/17/2024	Morgan Stanley 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$127.00 ➝ $136.00	+18.21%
12/13/2024	Wells Fargo & Company 3 of 5 stars	S. Baxter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underweight ➝ Equal Weight	$101.00 ➝ $127.00	+8.12%
12/4/2024	Mizuho 3 of 5 stars	A. Hynes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold ➝ Outperform	$139.00	+12.79%
11/4/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$119.00 ➝ $124.00	+9.48%
11/4/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$134.00 ➝ $139.00	+21.30%
11/4/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$117.00 ➝ $133.00	+14.53%
Get the Latest News and Ratings for CAH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.
9/11/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$115.00 ➝ $125.00	+10.34%
8/21/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$111.00 ➝ $123.00	+12.23%
8/15/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$130.00 ➝ $137.00	+28.81%
8/15/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	In-Line ➝ In-Line	$105.00 ➝ $115.00	+8.12%
7/19/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$115.00 ➝ $107.00	+11.98%
2/26/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
2/26/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$125.00	+15.64%
8/16/2023	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$88.00 ➝ $90.00	-0.56%
7/17/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$91.00 ➝ $99.00	+6.29%
6/12/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$90.00 ➝ $100.00	+15.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 11:33 PM ET.

Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, December 22, 2024. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

Cardinal Health
Bull Case

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

Cardinal Health, Inc. has recently received a price target increase from Argus, raising it from $115.00 to $125.00, indicating positive analyst sentiment and potential for stock appreciation.
The company reported strong quarterly earnings, with an EPS of $1.88, surpassing analysts' expectations of $1.62, showcasing its ability to generate profits effectively.
With a current stock price of approximately $117.46, Cardinal Health, Inc. is trading near its 50-day moving average of $117.00, suggesting stability in its recent performance.
Cardinal Health, Inc. has a consensus rating of "Moderate Buy" from analysts, with nine analysts recommending a buy, which reflects overall confidence in the company's future performance.
The company has a market capitalization of around $28.43 billion, indicating it is a significant player in the healthcare sector, which can provide investors with a sense of security in their investment.

Cardinal Health
Bear Case

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

Cardinal Health, Inc. has experienced a revenue decline of 4.3% compared to the same quarter last year, which may raise concerns about its growth trajectory.
The company has a negative return on equity of 56.56%, indicating that it is not effectively generating profits from its equity, which could be a red flag for potential investors.
Despite a recent dividend declaration, the company has cut its dividend, which may signal financial strain and could deter income-focused investors.
Cardinal Health, Inc. has a relatively low net margin of 0.56%, suggesting that it retains a small portion of its revenue as profit, which may limit its ability to reinvest in growth opportunities.
One investment analyst has rated the stock with a sell rating, which could indicate potential risks or concerns that investors should consider before investing.

CAH Forecast - Frequently Asked Questions

: According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Cardinal Health is $127.50, with a high forecast of $139.00 and a low forecast of $107.00.
: 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CAH shares.
: According to analysts, Cardinal Health's stock has a predicted upside of 8.12% based on their 12-month stock forecasts.
: Over the previous 90 days, Cardinal Health's stock had 1 upgrade by analysts.
: Cardinal Health has been rated by research analysts at Barclays, Deutsche Bank Aktiengesellschaft, Mizuho, Morgan Stanley, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Cardinal Health less than other "medical" companies. The consensus rating score for Cardinal Health is 2.62 while the average consensus rating score for "medical" companies is 2.81. Learn more on how CAH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

This page (NYSE:CAH) was last updated on 12/30/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cardinal Health (CAH) Stock Forecast & Price Target